Interested in finding more jobs in Richmond, VA? Click Here to create a Climber profile today!



Kaleo Inc. Work Values

Interested in finding out if you are the type of person this company is looking for? Create an account and take our patented DNA assessment now to see how you compare.


Daily Duties at Kaleo Inc.:

Director of medical affairs strategy and tactics; director MSL team; MSL


What they like about Kaleo Inc.:

A hiring company that offers alternative approaches to pay, performance bonuses, and/or equity in the firm is very attractive to you. You're generally less interested in working for an organization offering only traditional, salary-based compensation, one with limited opportunity to acquire equity in the firm, or one that does not actively promote skill development. In addition, you are more likely to choose a company that offers a variety of internal career options, with defined career paths. You view the learning of new skills and development of your expertise as key to your career advancement. These aspects of an organization may become even more important to you as you progress in your field, and are especially critical if you change career or occupation.



Information about Kaleo Inc.


Company Rank: Not Available

Average length of employment : 2 years

Average salary of employees: $200,000

These are some of the questions we asked our climbers about their experiences with Kaleo Inc.:

05|
Were your performance expectations clearly communicated?

0.0

Were you recognized for meeting or exceeding expectations?

0.0

Did you feel like your personal contribution was important?

0.0

Was your career path clearly outlined and discussed?

0.0


03|
I would recommend this as a place of employment.
0.0
I believe in the purpose of this organization.
0.0
I would work for this organization again.
0.0
I feel employees are fairly compensated.
0.0


Climbers who worked at Kaleo Inc. had these interests:

Websites
Google Scholar

http://googlescholar.com

Updates in science
Pink Sheet

http://pinksheet.com

Updates in biopharmaceutical industry


Back